IP Library Granted Patent US 12,151,017
Granted Patent B2
US 12,151,017 · App. 17/567,564 · Granted Nov 26, 2024

Compositions and methods for hair regrowth

Inventors: Myriam Morley (Westerly, RI); Sophia Kogan (New York, NY); Roland Peralta (New York, NY); Giorgos Tsetis (New York, NY)
Assignee: Nutraceutical Wellness, Inc.
A61K8/9783A23L33/105A61K8/20A61K8/347A61K8/65A61K8/671A61K8/673A61K8/676A61K8/678A61K8/735A61Q7/00A61P17/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,151,017
App. No.
17/567,564
Granted
Nov 26, 2024
Kind
B2
Abstract

The disclosure provides compositions and methods for promoting hair growth and reducing hair loss using bioactive extracts of curcumin, Withania somnifera , and saw palmetto. Tocotrienols, tocopherols, piperine extract, low molecular weight collagen, and hyaluronic acid are optionally included in the compositions and methods.

Claims (23)

1. A method of improving hair loss caused by medication side effects, comprising administering to a subject in need thereof an effective amount of a composition comprising:

about 100 mg to 1000 mg of an extract of Curcuma longa,

from about 100 mg to 1000 mg of an extract of the roots and leaves of Withania somnifera,

at least about 200 mg of saw palmetto extract,

from about 225 mcg to 300 mcg of iodine, and

a pharmaceutically acceptable encapsulating material, for a time sufficient to improve hair loss.

2. The method of claim 1 , wherein the medication side effects are caused by chemotherapy.

3. The method of claim 1 , wherein said iodine is provided by kelp.

4. The method of claim 1 , wherein the composition further comprises from about 100 mg to about 1000 mg of tocotrienols and tocopherols.

5. The method of claim 1 , wherein the composition further comprises low molecular weight collagen and hyaluronic acid.

6. The method of claim 5 , wherein said collagen is Type I and Type III collagen and has a molecular weight of less than 5000 daltons.

7. The method of claim 5 , wherein said collagen is present in an amount from about 500 mg to about 2000 mg, and said hyaluronic acid is present in an amount from about 100 mg to about 1000 mg.

8. The method of claim 1 , wherein the composition further comprises at least about 5 mg of piperine.

9. The method of claim 1 , wherein the composition further comprises one or more compounds selected from the group consisting of green tea extract, L-methionine, L-cysteine hydrochloride, resveratrol, capsaicin, biotin, selenium, Vitamin D, Vitamin A, Vitamin C, choline, calcium and copper.

10. A method of improving hair loss caused by medication side effects, comprising administering to a subject in need thereof an effective amount of a composition comprising:

at least about 200 mg of curcumin,

at least about 100 mg of withanolides,

at least about 200 mg of saw palmetto extract,

at least about 100 mg of tocotrienols and tocopherols comprising a complex of about 78% tocotrienols and about 22% tocopherols,

at least about 225 mcg of iodine,

at least about 1000 mg of Type I and III collagen having a molecular weight of less than about 3000 Daltons,

at least about 100 mg of hyaluronic acid, and

a pharmaceutically acceptable encapsulating material, for a time sufficient to improve hair loss.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 10, 2025
From: PERALTA, ROLAND; TSETIS, GIORGOS; MORLEY, MYRIAM; KOGAN, SOPHIA
To: NUTRACEUTICAL WELLNESS INC
Reel/Frame 070157/0796 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 23, 2022
From: PERALTA, ROLAND; TSETIS, GIORGOS
To: NUTRACEUTICAL WELLNESS, INC.
Reel/Frame 060297/0021 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 5, 2022
From: MORLEY, MYRIAM; KOGAN, SOPHIA
To: NUTRACEUTICAL WELLNESS INC
Reel/Frame 058560/0070 →
Continuity (4)
Division 16908424 · Jun 22, 2020
Continuation 15898206 · Feb 15, 2018
Continuation In Part 14986525 · Dec 31, 2015
Related Publication 20220125707A1 · Apr 28, 2022